Cargando…
Rapid screening for severe acute respiratory syndrome coronavirus 2 infection with a combined point-of-care antigen test and an immunoglobulin G antibody test
Rapid screening and diagnosis of coronavirus disease 2019 in the emergency department is important for controlling infections. When polymerase chain reaction tests cannot be rapidly performed, rapid antigen testing is often used, albeit with insufficient sensitivity. Therefore, we evaluated the diag...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8806068/ https://www.ncbi.nlm.nih.gov/pubmed/35104281 http://dx.doi.org/10.1371/journal.pone.0263327 |
_version_ | 1784643366944768000 |
---|---|
author | Mori, Kosuke Imaki, Shohei Ohyama, Yutaro Satoh, Kosuke Abe, Takeru Takeuchi, Ichiro |
author_facet | Mori, Kosuke Imaki, Shohei Ohyama, Yutaro Satoh, Kosuke Abe, Takeru Takeuchi, Ichiro |
author_sort | Mori, Kosuke |
collection | PubMed |
description | Rapid screening and diagnosis of coronavirus disease 2019 in the emergency department is important for controlling infections. When polymerase chain reaction tests cannot be rapidly performed, rapid antigen testing is often used, albeit with insufficient sensitivity. Therefore, we evaluated the diagnostic accuracy of combining rapid antigen and antibody test results. This was a retrospective review of patients who visited our emergency department between February and May 2021 and underwent rapid antigen, immunoglobulin G antibody, and reverse transcription–polymerase chain reaction tests. The study included 1,070 patients, of whom 56 (5.2%) tested positive on reverse transcription–polymerase chain reaction. The sensitivity, specificity, and area under the curve of rapid antigen testing were 73.7%, 100.0%, and 0.87, respectively. The combined rapid antigen and antibody test result had improved diagnostic accuracy, with 91.2% sensitivity, 97.9% specificity, and an area under the curve of 0.95. The results of the rapid antigen and antibody tests could be combined as a reliable alternative to reverse transcription–polymerase chain reaction. |
format | Online Article Text |
id | pubmed-8806068 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-88060682022-02-02 Rapid screening for severe acute respiratory syndrome coronavirus 2 infection with a combined point-of-care antigen test and an immunoglobulin G antibody test Mori, Kosuke Imaki, Shohei Ohyama, Yutaro Satoh, Kosuke Abe, Takeru Takeuchi, Ichiro PLoS One Research Article Rapid screening and diagnosis of coronavirus disease 2019 in the emergency department is important for controlling infections. When polymerase chain reaction tests cannot be rapidly performed, rapid antigen testing is often used, albeit with insufficient sensitivity. Therefore, we evaluated the diagnostic accuracy of combining rapid antigen and antibody test results. This was a retrospective review of patients who visited our emergency department between February and May 2021 and underwent rapid antigen, immunoglobulin G antibody, and reverse transcription–polymerase chain reaction tests. The study included 1,070 patients, of whom 56 (5.2%) tested positive on reverse transcription–polymerase chain reaction. The sensitivity, specificity, and area under the curve of rapid antigen testing were 73.7%, 100.0%, and 0.87, respectively. The combined rapid antigen and antibody test result had improved diagnostic accuracy, with 91.2% sensitivity, 97.9% specificity, and an area under the curve of 0.95. The results of the rapid antigen and antibody tests could be combined as a reliable alternative to reverse transcription–polymerase chain reaction. Public Library of Science 2022-02-01 /pmc/articles/PMC8806068/ /pubmed/35104281 http://dx.doi.org/10.1371/journal.pone.0263327 Text en © 2022 Mori et al https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Article Mori, Kosuke Imaki, Shohei Ohyama, Yutaro Satoh, Kosuke Abe, Takeru Takeuchi, Ichiro Rapid screening for severe acute respiratory syndrome coronavirus 2 infection with a combined point-of-care antigen test and an immunoglobulin G antibody test |
title | Rapid screening for severe acute respiratory syndrome coronavirus 2 infection with a combined point-of-care antigen test and an immunoglobulin G antibody test |
title_full | Rapid screening for severe acute respiratory syndrome coronavirus 2 infection with a combined point-of-care antigen test and an immunoglobulin G antibody test |
title_fullStr | Rapid screening for severe acute respiratory syndrome coronavirus 2 infection with a combined point-of-care antigen test and an immunoglobulin G antibody test |
title_full_unstemmed | Rapid screening for severe acute respiratory syndrome coronavirus 2 infection with a combined point-of-care antigen test and an immunoglobulin G antibody test |
title_short | Rapid screening for severe acute respiratory syndrome coronavirus 2 infection with a combined point-of-care antigen test and an immunoglobulin G antibody test |
title_sort | rapid screening for severe acute respiratory syndrome coronavirus 2 infection with a combined point-of-care antigen test and an immunoglobulin g antibody test |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8806068/ https://www.ncbi.nlm.nih.gov/pubmed/35104281 http://dx.doi.org/10.1371/journal.pone.0263327 |
work_keys_str_mv | AT morikosuke rapidscreeningforsevereacuterespiratorysyndromecoronavirus2infectionwithacombinedpointofcareantigentestandanimmunoglobulingantibodytest AT imakishohei rapidscreeningforsevereacuterespiratorysyndromecoronavirus2infectionwithacombinedpointofcareantigentestandanimmunoglobulingantibodytest AT ohyamayutaro rapidscreeningforsevereacuterespiratorysyndromecoronavirus2infectionwithacombinedpointofcareantigentestandanimmunoglobulingantibodytest AT satohkosuke rapidscreeningforsevereacuterespiratorysyndromecoronavirus2infectionwithacombinedpointofcareantigentestandanimmunoglobulingantibodytest AT abetakeru rapidscreeningforsevereacuterespiratorysyndromecoronavirus2infectionwithacombinedpointofcareantigentestandanimmunoglobulingantibodytest AT takeuchiichiro rapidscreeningforsevereacuterespiratorysyndromecoronavirus2infectionwithacombinedpointofcareantigentestandanimmunoglobulingantibodytest |